It's certainly a major medical need in the ability to prevent cervical cancer. That gives it the potential to be a blockbuster. We're not expecting a real quick ramp up on this, though it could become a billion dollar drug.
Pfizer is becoming a value play. You're certainly not expecting a lot of growth in the future.